摘要
目的: 肿瘤抑制因子p53是细胞凋亡的主要调节因子,在细胞周期检测中起着关键作用。在我们之前的研究中,我们证明p53直接调节小鼠jb6细胞中的Bak,p53 Bak信号轴在介导EGCG诱导的凋亡中起着重要作用。此外,我们最近证明,同样的p53-Bak凋亡信号轴在调节晶状体细胞分化中起着重要作用。此外,我们还发现p53控制转录因子C-Maf 和 Prox-1,以及晶状体晶体蛋白基因αa、β和γ-晶体蛋白。在这里,我们研究了p53在调节晶状体分化过程中是否也调节其他已知的靶基因。人和小鼠晶状体上皮细胞FHL124 和αTN4-1在含有10%胎牛血清和1%青霉素链霉素的Dulbecco改良Eagle''s培养基(DMEM)中培养。 方法: 本研究中使用的小鼠按照《实验动物护理和使用协议》(中山大学)进行处理。用成年小鼠采集晶状体细胞。这些样品被用来提取总蛋白。共有32只胚胎小鼠8只(14.5 d)、8只(17.5 d)和8只野生型新生儿用于免疫组化,用于共定位研究。用qRT-PCR分析mRNA水平。蛋白质水平用蛋白质印迹分析法测定,并用图像J定量。 结果: 免疫组化显示,细胞周期检测基因p21和Gadd45α以及凋亡基因Bcl-2 和 PUMA在小鼠晶状体发育过程中均显示与p53相关的发育变化。小鼠晶状体上皮细胞p53的敲除抑制了晶状体的分化。与此抑制相关的细胞周期基因表现出明显的下调,凋亡基因也减弱,但程度要小得多。此外,我们发现bFGF可以诱导上游激酶CHK1/2和ERK1/2的剂量依赖性上调,这两种激酶都已知磷酸化p53并激活后者。此外,我们还发现,在发育中的晶状体和人晶状体上皮细胞中,p53都可以与蛋白磷酸酶1(PP-1)的催化亚单位共定位,这表明PP-1在体内和体外都能调节p53的磷酸化状态。 结论: 综上所述,我们的结果表明,在小鼠晶状体发育过程中,p53的活性受ERK和CHK激酶介导的激活和PP-1介导的失活的调节。p53能调控多组基因介导晶状体分化。
关键词: p53
Current Molecular Medicine
Title:The Sumoylation Modulated Tumor Suppressor p53 Regulates Cell Cycle Checking Genes to Mediate Lens Differentiation
Volume: 18 Issue: 8
关键词: p53
摘要: Purpose: The tumor suppressor p53 is a master regulator of apoptosis and also plays a key role in cell cycle checking. In our previous studies, we demonstrated that p53 directly regulates Bak in mouse JB6 cells and that p53-Bak signaling axis plays an important role in mediating EGCG-induced apoptosis. Furthermore, we have recently demonstrated that the same p53-Bak apoptotic signaling axis executes an essential role in regulating lens cell differentiation. In addition, we have also shown that p53 controls both transcription factors, C-Maf and Prox-1 as well as lens crystallin genes, αA, β- and γ-crystallins. Here, we have examined whether p53 also regulates other known target genes during its modulation of lens differentiation. The human and mouse lens epithelial cells, FHL124 and αTN4-1 were cultured in Dulbecco’s modified Eagle’s medium (DMEM) containing 10% fetal bovine serum (FBS) and 1% Penicillin-Streptomycin.
Methods: Mice used in this study were handled in compliance with the “Protocol for the Care and Use of Laboratory Animals” (Sun Yat-sen University). Adult mice were used for the collection of lens cells. These samples were used for extraction of total proteins. A total of 32 embryonic mice {8 at 14.5 ED, 8 at 17.5 ED and 8 newborns for wild type} were used for immunohistochemistry, which were used for co-localization study. The mRNA levels were analysed with qRT-PCR. The protein levels were determined with western blot analysis and quantitated with Image J.
Results: Immunohistochemistry revealed that both the cell cycle checking genes, p21 and Gadd45α and the apoptotic genes, Bcl-2 and PUMA, display developmental changes associated with p53 during mouse lens development. Knockdown of p53 in the mouse lens epithelial cells caused inhibition of lens differentiation. Associated with this inhibition, the cell cycle genes displayed significant downreglation, the apoptotic genes was also attenuated but to a much less degree. In addition, we found that bFGF can induce dose-dependent upregulation of the upstream kinases, CHK1/2 and ERK1/2, both known to phosphorylate p53 and activate the later. Furthermore, We showed that in both developing lens and human lens epithelial cells, p53 can be co-localized with the catalytic subunit of the protein phoshphatase-1 (PP-1), suggesting that PP-1 regulates p53 phosphorylation status both in vivo and in vitro.
Conclusion: Taken together, our results suggest that during mouse lens development, p53 activity is regulated by ERK and CHK kinases-mediated activation, and by PP-1-mediated inactivation. p53 can regulate multiple groups of genes to mediate lens differentiation.
Export Options
About this article
Cite this article as:
The Sumoylation Modulated Tumor Suppressor p53 Regulates Cell Cycle Checking Genes to Mediate Lens Differentiation, Current Molecular Medicine 2018; 18 (8) . https://dx.doi.org/10.2174/1566524019666190111154450
DOI https://dx.doi.org/10.2174/1566524019666190111154450 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers